Carregant...

Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial

BACKGROUND: Smoking cessation is a key component of secondary cardiovascular disease prevention. Varenicline, a partial α4β2 nicotinic acetylcholine receptor agonist, is effective for smoking cessation in healthy smokers, but its efficacy and safety in smokers with cardiovascular disease are unknown...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rigotti, Nancy A., Pipe, Andrew L., Benowitz, Neal L., Arteaga, Carmen, Garza, Dahlia, Tonstad, Serena
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4096941/
https://ncbi.nlm.nih.gov/pubmed/20048210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.109.869008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!